T. Rowe Price Associates’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $649M | Buy |
7,023,689
+1,387,611
| +25% | +$139M | 0.08% | 210 |
|
|
2025
Q4 | $576M | Buy |
5,636,078
+1,414,441
| +34% | +$127M | 0.06% | 227 |
|
|
2025
Q3 | $264M | Buy |
4,221,637
+2,456,061
| +139% | +$134M | 0.03% | 396 |
|
|
2025
Q2 | $91.9M | Buy |
1,765,576
+1,136,068
| +180% | +$50.7M | 0.01% | 587 |
|
|
2025
Q1 | $26.8M | Buy |
629,508
+533,104
| +553% | +$23M | ﹤0.01% | 880 |
|
|
2024
Q4 | $2.95M | Sell |
96,404
-746,104
| -89% | -$21M | ﹤0.01% | 1466 |
|
|
2024
Q3 | $19.3M | Sell |
842,508
-533,166
| -39% | -$15.1M | ﹤0.01% | 1002 |
|
|
2024
Q2 | $39.7M | Sell |
1,375,674
-169,440
| -11% | -$3.95M | ﹤0.01% | 788 |
|
|
2024
Q1 | $31.9M | Sell |
1,545,114
-274,470
| -15% | -$5.88M | ﹤0.01% | 848 |
|
|
2023
Q4 | $49.2M | Sell |
1,819,584
-926,378
| -34% | -$24.3M | 0.01% | 719 |
|
|
2023
Q3 | $81.4M | Sell |
2,745,962
-1,469,418
| -35% | -$51.7M | 0.01% | 552 |
|
|
2023
Q2 | $151M | Buy |
4,215,380
+2,532,687
| +151% | +$72.7M | 0.02% | 442 |
|
|
2023
Q1 | $39.4M | Sell |
1,682,693
-20,287
| -1% | -$579K | 0.01% | 748 |
|
|
2022
Q4 | $46.3M | Buy |
1,702,980
+108,381
| +7% | +$4.96M | 0.01% | 686 |
|
|
2022
Q3 | $85.8M | Buy |
1,594,599
+23,857
| +2% | +$1.22M | 0.01% | 517 |
|
|
2022
Q2 | $63.4M | Buy |
1,570,742
+227,675
| +17% | +$11.3M | 0.01% | 806 |
|
|
2022
Q1 | $89M | Buy |
1,343,067
+33,150
| +3% | +$2.27M | 0.01% | 765 |
|
|
2021
Q4 | $131M | Sell |
1,309,917
-1,847,006
| -59% | -$191M | 0.01% | 685 |
|
|
2021
Q3 | $395M | Buy |
3,156,923
+1,577,628
| +100% | +$187M | 0.04% | 388 |
|
|
2021
Q2 | $196M | Buy |
1,579,295
+38,411
| +2% | +$5.17M | 0.02% | 564 |
|
|
2021
Q1 | $235M | Buy |
1,540,884
+108,510
| +8% | +$16.4M | 0.02% | 510 |
|
|
2020
Q4 | $185M | Buy |
1,432,374
+117,511
| +9% | +$13.5M | 0.02% | 546 |
|
|
2020
Q3 | $147M | Sell |
1,314,863
-153,627
| -10% | -$14.1M | 0.02% | 555 |
|
|
2020
Q2 | $119M | Sell |
1,468,490
-371,320
| -20% | -$29.9M | 0.02% | 586 |
|
|
2020
Q1 | $128M | Sell |
1,839,810
-1,260,464
| -41% | -$96.7M | 0.02% | 509 |
|
|
2019
Q4 | $242M | Buy |
3,100,274
+1,077,872
| +53% | +$77.7M | 0.03% | 443 |
|
|
2019
Q3 | $129M | Buy |
2,022,402
+272,972
| +16% | +$24M | 0.02% | 546 |
|
|
2019
Q2 | $151M | Buy |
1,749,430
+334,218
| +24% | +$25.5M | 0.02% | 530 |
|
|
2019
Q1 | $107M | Buy |
1,415,212
+8,916
| +0.6% | +$494K | 0.02% | 619 |
|
|
2018
Q4 | $52M | Buy |
+1,406,296
| New | +$51.8M | 0.01% | 804 |
|
Other funds holding GH
VPM
VCM
